SearchSearch results for: “”

Stibbe represented VodafoneZiggo in a dispute with Fox Sports concerning the length of the contracts and the level of fees Ziggo has to pay Fox for broadcasting the football channels in the Netherlands.

Stibbe advised Aedifica recently on two transactions in order to further expand her Dutch portfolio of care assets.

Stibbe represents voestalpine in antitrust damage litigation following on from the European Commission's finding of an antitrust infringement in the pre-stressing steel sector

Stibbe advises Aedifica on the acquisition of a care residence that will be constructed in Leersum. Aedifica acquired the full property of the site from Woudenburcht B.V., a local real estate developer. See for the press release here.

Stibbe represented Simed International in a dispute with the privately-owned Slotervaart hospital in Amsterdam. The Slotervaart hospital claimed that Simed International had sent incorrect invoices to the Slotervaart hospital, which would therefore have b

Stibbe represented members of the Supervisory Board of the Dutch professional football club FC Twente when the club faced financial difficulties in 2016.

Stibbe assisted the Belgian Buildings Agency in its claim for time extension and additional payment and in a litigation with the contractor concerning the ‘Residence Palace Building’, a new landmark in Brussels that will be the seat of the EU Council.

Successfully defended the global train manufacturer Bombardier Transportation in a dispute with the Israeli insurance company Phoenix. The dispute related to two fire incidents that occurred in Israel in 2001,  involving trains supplied by Bombardier Tran

Stibbe represented a global lifts manufacturer in several antitrust damage proceedings in Belgium brought by several entities, including the European Commission, following the European Commission's finding of an antitrust infringement in the elevator and

Stibbe represented Ballast Nedam and its subsidiaries in a major corporate fraud dispute with a former director and several other parties, including suppliers.

Stibbe assisted a client in the pharmaceutical sector with conducting an in-depth legal assessment regarding the scope and modalities of the safety features to be added to (the packaging of) medicinal products.

Representing ABN AMRO in a major dispute with inter alia former group companies Fortis N.V. and Fortis SA/NV (renamed: Ageas).

Advising Forbion Capital Partners on the delisting of Amsterdam Molecular Therapeutics (AMT) Holding.

Stibbe advised a plasma protein biotherapeutics company on Belgium's implementation of a new Act on public procurement law that obliges Belgian hospitals to conduct a public procurement process for public contracts for the supply of medicinal products.

Stibbe assisted a leading Belgian bank with a number of highly complex and sensitive litigation cases about the sale of Collateralized Debt Obligations (CDOs) to corporate and private clients during the period 2005-2007.

Stibbe advised a leading biotechnology company on the legal aspects of clinical trials development for biotech medicinal products.